Inflammatory bowel disease patients rely on phone communication as much as or more than doctor visits for management of their disease, and heavier reliance may be a sign of impending emergency...
CHICAGO – Patients with cirrhosis and medium to large esophageal varices were 81% less likely to develop a first esophageal variceal bleed within 5 years if they took rifaximin to manage hepatic...
CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans.
Although hepatocellular carcinoma (HCC) in patients...
CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans.
Although hepatocellular carcinoma (HCC) in patients...
CHICAGO – Fluorescence in situ hybridization testing for aneuploidy and loss of the tumor suppressor gene P16 can be useful in predicting progression to high-grade dysplasia and adenocarcinoma in...
CHICAGO – A genomewide association study has identified specific alleles that may pinpoint those at risk for thiopurine-induced pancreatitis in inflammatory bowel disease.
Patients heterozygous at...
The investigational monoclonal antibody etrolizumab effected clinical remission in significantly more patients with refractory ulcerative colitis than did placebo, an industry-sponsored trial...
CHICAGO – Treatment with an intragastric balloon before bariatric surgery produces significant weight loss in the morbidly obese, but at the cost of more surgical complications, according to the...